ZHEJIANG ANG

Zhejiang Angda Jiuli Biopharmaceutical Co., Ltd. is a high-tech biopharmaceutical enterprise based in China and looking to the world, integrating R&D, production and sales operations. The company's core product is recombinant exenatide human serum albumin fusion protein, referred to as E2HSA (Chinese: Zhou Kening), which has obtained the national invention patent certificate. It is an anti-type II diabetes ultra-long-acting biological innovative drug produced by recombination and optimization on the basis of yeast cultivation.

Also known as: Zhejiang Ang Da, Zhejiang Angda Jiuli Biopharmaceutical Co